Neolacta Lifesciences is the 1st and only company in India and Asia to have developed 100% human milk-based products to address the needs of neonatal nutrition and to help improve ‘Intact Survival’ rates for premature babies.
India ranks 5th out of 52 countries on the neonatal mortality rate index and bears the burden of a high neonatal mortality rate of 21.7 per 1,000 births, according to United Nations Inter-Agency Group for Child Mortality Estimation (UN IGME).
A majority of all neonatal deaths (75%) occur during the first week of life. Major causes of mortality include Prematurity, Birth asphyxia, Sepsis, Pneumonia and Diarrhea. Premature babies are more prone to infections of the gut and respiratory tract which, may develop complications with long-term implications.
Now, with the development of 100% human milk-based products through proprietary processing technologies, NeoLacta Lifesciences is changing the landscape of neonatal care in India.
Dr. Geetika Gangwani, Lactation Consultant emphasized that improving intact survival rates requires strengthening the quality of care as well as ensuring availability of human milk diet for all newborns. Recently, a premature baby who lost his mother soon after birth due to Covid-19 was rescued by providing pasteurized human breast milk supplied by NeoLacta Lifesciences.
Dr. Vikram Reddy, Chief Scientific Officer, NeoLacta Lifesciences says that human milk provides antibodies and is easily digestible. It contains optimal nutrients, and is gentle on the baby’s developing stomach, intestines and other body systems. Thus, it provides natural immunity for fighting infectious diseases and preventing chronic health disorders.
NeoLacta Lifesciences have introduced a range of innovative 100% human milk-based products to improve the quality of nutritional care for newborns. These are pasteurised and standardised donor milk, powdered human milk for reconstitution, and a patented Mother’s Milk Fortifier. Over the last 5 years, these products are being used in over 200+ super-specialty hospitals across India.
Mothers who struggle with breastfeeding, now have an option of providing pasteurised human breast milk from NeoLacta, thereby completely avoiding bovine milk-based products such as formulas, from the baby’s diet.
While breastfeeding alone is sufficient for most infants, premature babies need a helping hand as they are at a high risk of suffering from growth deficits. NeoLact MMF (Mother’s Milk Fortifier) is a revolutionary product for feed fortification in premature and sick babies who need higher nutrient intakes to match the growth rates with their term-born peers.
Buoyed by the overwhelming response of clinicians and backed by a robust logistical network covering most metros and major cities, NeoLacta Lifesciences has embarked on a mission towards improving access to human milk through its range of 100% human milk-based products, concludes Dr. Vikram Reddy, Chief Scientific Officer, NeoLacta.
About Neolacta Lifesciences
NeoLacta is the 1st and only company in India and Asia to have developed a state-of-the-art human milk processing facility compliant to pasteurising guidelines of World Health Organization along with being ISO 22000:2018 certified, GMP compliant and FSSAI approved. This helps caregivers and decision makers adhere to a 100% human milk diet without having to rely on bovine milk-based products which also contain multiple synthetic additives.
All proprietary equipment has been designed & built by an in-house engineering team to ensure highest level of safety, hygiene and quality. NeoLacta is the only human milk facility in India to have ISO cleanrooms, HACCP certified process, onsite R&D, chemical and microbial labs and walk-in freezers which distinguishes NeoLacta from any standard human milk bank. Moreover, the proprietary technologies used for processing makes India the 2nd nation globally after US to have a facility of this kind.
Continuing the legacy of supporting parents and clinicians by providing 100% human milk-based neonatal products, operations have been recently launched in United Kingdom under the banner of NeoKare Nutrition. The founders of both the organisations, NeoLacta and NeoKare, have extensive background in human milk technology since they were instrumental in establishing the 1st milk bank in Australia at KEM, Perth, WA in 2000.